Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer’s disease-like pathology
Journal of Neural Transmission · 2025-10 · 132 (10) · 1493-1514
DOI: 10.1007/s00702-025-02896-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neural Transmission, online erschienen am 22.02.2025. Verfasst von Suélen Santos Alves und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil. Hauptthemen laut MEDLINE: Alzheimer Disease, Signal Transduction, Insulin, Memory Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) and epilepsy exhibit a complex bidirectional relationship. Curiously, diabetes as a comorbidity increases the risk of epilepsy among AD patients. Recently, we reported that the Wistar audiogenic rat (WAR) strain, a genetic model of epilepsy, displays a partial AD-like phenotype, including brain insulin resistance. We also assessed seizure susceptibility in an AD model created through intracerebroventricular injections of streptozotocin (icv-STZ), which induces AD features via brain insulin resistance. Our goal was to explore how disrupted brain insulin signaling influences AD-like features and seizure susceptibility in the WAR strain. Adult male WARs received a single intracerebroventricular injection of streptozotocin (icv-STZ) (1.5 mg/kg) or vehicle (saline). Two weeks post-injection, spatial memory was assessed using the Barnes Maze (BM) test. Three weeks later, the rats underwent an audiogenic kindling (AuK) protocol (20 acoustic stimuli, 2 per day) to evaluate seizure frequency and severity. Seizures were analyzed using the Categorized Severity Index and Racine's scale and Western blot analysis was performed on hippocampal tissue. Our findings revealed that icv-STZ significantly worsened memory performance, increased seizure frequency, and reduced seizure onset relative to vehicle. Furthermore, icv-STZ decreased Akt activation and increased Glycogen Synthase Kinase-3 (GSK3) phosphorylation, indicating disrupted insulin signaling. Notably, icv-STZ decreased tau phosphorylation without altering amyloid β precursor protein (AβPP) levels. In conclusion, a low-dose icv-STZ injection exacerbates memory deficits and seizure susceptibility in the WAR strain by disturbing downstream proteins involved in insulin signaling. This highlights the implications of brain insulin resistance in both AD and epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil.
- Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, Av. Dos Bandeirantes 3900, Ribeirão Preto, SP, 14049-900, Brazil.
- Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil.
- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
- Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil. ngcairas@usp.br.
- Department of Physiology, Ribeirão Preto Medical School, University of São Paulo, Av. Dos Bandeirantes 3900, Ribeirão Preto, SP, 14049-900, Brazil. ngcairas@usp.br.
ORCID-Profile: Norberto Garcia-Cairasco
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Instituto de Salud Carlos III
- 'la Caixa' Foundation
Zitieren
APA
Alves, S. S., Servilha-Menezes, G., Rossi, L., de Oliveira, J. A. C., Grigorio-de-Sant'Ana, M., Sebollela, A., da Silva-Junior, R. M. P., & Garcia-Cairasco, N. (2025). Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer’s disease-like pathology. Journal of Neural Transmission, 132(10), 1493-1514. https://doi.org/10.1007/s00702-025-02896-1
Vancouver
Alves SS, Servilha-Menezes G, Rossi L, de Oliveira JAC, Grigorio-de-Sant'Ana M, Sebollela A, et al. Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer’s disease-like pathology. Journal of Neural Transmission. 2025;132(10):1493-1514. doi:10.1007/s00702-025-02896-1
BibTeX
@article{Alves2025,
author = {Alves, Suélen Santos and Servilha-Menezes, Gabriel and Rossi, Letícia and de Oliveira, José Antonio Cortes and Grigorio-de-Sant'Ana, Mariana and Sebollela, Adriano and da Silva-Junior, Rui Milton Patrício and Garcia-Cairasco, Norberto},
title = {Insulin signaling disruption exacerbates memory impairment and seizure susceptibility in an epilepsy model with Alzheimer’s disease-like pathology},
journal = {Journal of Neural Transmission},
year = {2025},
volume = {132},
number = {10},
pages = {1493--1514},
doi = {10.1007/s00702-025-02896-1}
}
EUVIMED